✦ LIBER ✦

Enhanced sensitivity to alkylating agent in lymphocytes from patients with multiple endocrine neoplasia type 1

✍ Scribed by Y. Itakura; A. Sakurai; M. Katai; Y. Ikeo; K. Hashizume

Book ID: 117575150
Publisher: Elsevier Science
Year: 2000
Tongue: English
Weight: 262 KB
Volume: 54
Category: Article
ISSN: 0753-3322
DOI: 10.1016/s0753-3322(00)80041-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Chromosome aberrations in lymphocyte and

Chromosome aberrations in lymphocyte and in fibroblast cultures from patients with multiple endocrine neoplasia type 1.

✍ S. Scappaticci; P. Maraschio; N. del Ciotto; G.S. Fossati; A. Zonta 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 45 KB

Fibroblast Growth Factor–like Autoantibo

Fibroblast Growth Factor–like Autoantibodies in Plasma from Patients with Multiple Endocrine Neoplasia Type 1 and Prolactinoma

✍ M. B. ZIMERING; N. KATSUMATA; H. G. FRIESEN; J. ENG; D. J. RILEY; S. THAKKER-VAR 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 190 KB

Allele Loss on Chromosome 11 in a Pituit

Allele Loss on Chromosome 11 in a Pituitary Tumor from a Patient with Multiple Endocrine Neoplasia Type 1

✍ Yoshimoto, Katsuhiko ;Iwahana, Hiroyuki ;Kubo, Katsuyuki ;Saito, Shiro ;Itakura, 📂 Article 📅 1991 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 236 KB

A metastatic neuroendocrine anaplastic s

A metastatic neuroendocrine anaplastic small cell tumor in a patient with multiple endocrine neoplasia type 1 syndrome. Assessment of disease status and response to doxorubicin, cyclophosphamide, etoposide chemotherapy through scintigraphic imaging with 111in-pentetreotide

✍ Kenneth J. O'Byrne; Michael G. Goggins; Dermot P. Kelleher; Donald G. Weir; Geor 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 635 KB

Extrapulmonary small cell and small cell neuroendocrine tumors of unknown primary site are, in general, aggressive neoplasms with a short median survival. Like small cell lung cancer (SCLC), they often are responsive to chemotherapy and radiotherapy. Small cell lung cancer and well differentiated ne